Skip to main content
Natasha Robinette, MD, Radiology, Detroit, MI

NatashaLynneRobinetteMD

Radiology Detroit, MI

Neuroradiology

Karmanos Cancer Center Clinical Service Chief, Imaging Division

Dr. Robinette is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Robinette's full profile

Already have an account?

  • Office

    4100 John R St
    Mailcode HP10ID
    Detroit, MI 48201
    Phone+1 313-576-9960

Education & Training

  • University of Michigan
    University of MichiganFellowship, Neuroradiology, 2007 - 2008
  • Corewell Health East Beaumont (Dearborn)
    Corewell Health East Beaumont (Dearborn)Residency, Radiology-Diagnostic, 2003 - 2007
  • Corewell Health East Beaumont (Dearborn & Taylor)
    Corewell Health East Beaumont (Dearborn & Taylor)Internship, Transitional Year, 2002 - 2003
  • Wayne State University School of Medicine
    Wayne State University School of MedicineClass of 2002
  • Michigan State University
    Michigan State UniversityBS, Anthropology, 1990 - 1995
  • Michigan State University
    Michigan State UniversityBS, Physiology, 1990 - 1995

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2002 - 2026
  • American Board of Radiology Diagnostic Radiology
  • American Board of Radiology Neuroradiology

Awards, Honors, & Recognition

  • Special Recognition Award Wayne State University Department of Otolaryngology, 2011
  • Special Recognition Award Transitional Residency 2003
  • Co-Curricular Outreach Award Wayne State University, 2000

Publications & Presentations

PubMed

Journal Articles

  • Symptomatic CNS Radiation Necrosis Requiring Neurosurgical Resection During Treatment with Lorlatinib in ALK-Rearranged NSCLC: A Report of Two Cases  
    Zhu VW, Nagasaka M, Kubota T, Raval K, Robinette N, Armas O, Al-Holou W, Ou SI, Lung Cancer: Targets and Therapy, 1/14/2020
  • Amino Acid PET Amino Acid PET Imaging of the Early Metabolic Response During Tumor-Treating Fields (TTFields) Therapy in Recurrent Glioblastoma  
    Bosnyak E, Barger GR, Michelhaugh SK, Robinette NL, Amit-Yousif A, Mittal S, Juhasz C, Clinical Nuclear Medicine, 1/1/2018
  • Tryptophan PET predicts spatial and temporal patterns of posttreatment glioblastoma progression detected by contrast enhanced MRI  
    Bosnyak E, Kamson,DO, Robinette NL, Barger GR, Mittal S, Juhasz C, Neuro-Oncology, 1/1/2016
  • Join now to see all

Abstracts/Posters

  • Multimodal imaging-defined subregionsin newly- diagnosed Glioblastoma: Impact on Overall Survival
    Flora John, Edit Bosnyak, Natasha L. Robinette, Alit Yousif, Geoffrey R. Barger, Keval D. Shah, Sharon Michelhaugh, Sandeep Mittal, Csaba Juhasz, Society of Neuro-Oncology, New Orleans, LA, 1/15/2018
  • Automatic detection of high amino acid uptake regions in glioblastoma from multi-modal MRI: A full 3D U-net study of deeply learned PET data
    Jeong-Won Jeong, Min-Hee Lee, Flora John, Natasha L. Robinette, Alit Youssif, Geoffrey R. Barger, Keval D. Shah, Sandeep Mittal, Csaba Juhasz, Society of Neuro-Oncology, 1/1/2018
  • Amino acid PET and perfusion MRI in contrast-enhancing and non-enhancing regions of glioblastomas
    Bosnyak E, Flora J, Robinette NL, Yousif A, Barger GR, Mittal S, Juhasz C, Society for Neuro-Oncology, San Francisco, CA, 1/16/2017
  • Join now to see all

Lectures

  • Cranial Nerves and Perineural Tumor Spread 
    1/17/2018
  • Spaces of the Suprahyoid Neck 
    1/12/2018
  • MR Safety and Screening 
    1/17/2016
  • Join now to see all

Press Mentions

  • Volpara Highlights Cancer Risk Assessment, Breast Density Assessment and Mammography Quality Software at SBI 2023
    Volpara Highlights Cancer Risk Assessment, Breast Density Assessment and Mammography Quality Software at SBI 2023May 3rd, 2023
  • Volpara Risk Pathways’ Comprehensive Breast Cancer Risk Software Will Help Women to Receive Individualized Breast Care and Cancer Prevention Based on Their Risk Factors
    Volpara Risk Pathways’ Comprehensive Breast Cancer Risk Software Will Help Women to Receive Individualized Breast Care and Cancer Prevention Based on Their Risk FactorsApril 10th, 2023